Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
SZSE:000766.SZ
13.05 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,462.672 | 1,470.749 | 1,515.482 | 1,111.802 | 1,977.206 | 2,094.549 | 1,521.41 | 850.083 | 197.559 | 208.415 | 147.782 | 127.648 | 181.471 | 169.587 | 168.164 | 159.856 | 151.589 | 141.337 | 141.153 | 99.872 | 136.897 | 160.995 | 100.435 | 504.187 | 284.91 | 270.987 | 241.071 | 163.868 | 132.489 | 99.435 |
Cost of Revenue
| 410.35 | 353.209 | 352.84 | 224.302 | 339.902 | 341.363 | 324.066 | 265.731 | 96.448 | 79.376 | 72.234 | 57.302 | 76.351 | 65.848 | 65.561 | 64.34 | 67.128 | 66.027 | 58.776 | 49.7 | 50.141 | 39.434 | 30.474 | 70.477 | 103.892 | 114.277 | 75.389 | 47.68 | 50.473 | 49.94 |
Gross Profit
| 1,052.322 | 1,117.54 | 1,162.642 | 887.501 | 1,637.305 | 1,753.187 | 1,197.344 | 584.353 | 101.111 | 129.039 | 75.548 | 70.346 | 105.12 | 103.739 | 102.603 | 95.516 | 84.46 | 75.311 | 82.376 | 50.172 | 86.756 | 121.562 | 69.961 | 433.711 | 181.017 | 156.71 | 165.682 | 116.188 | 82.016 | 49.495 |
Gross Profit Ratio
| 0.719 | 0.76 | 0.767 | 0.798 | 0.828 | 0.837 | 0.787 | 0.687 | 0.512 | 0.619 | 0.511 | 0.551 | 0.579 | 0.612 | 0.61 | 0.598 | 0.557 | 0.533 | 0.584 | 0.502 | 0.634 | 0.755 | 0.697 | 0.86 | 0.635 | 0.578 | 0.687 | 0.709 | 0.619 | 0.498 |
Reseach & Development Expenses
| 44.931 | 64.909 | 63.515 | 50.33 | 66.912 | 67.303 | 51.55 | 28.582 | 0.263 | 1.668 | 0.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 29.366 | 25.513 | 30.099 | 105.388 | 73.399 | 54.522 | 39.71 | 44.128 | 14.853 | 18.239 | 13.792 | 11.816 | 41.77 | 33.777 | 33.807 | 30.621 | 30.889 | 35.182 | 35.46 | 182.599 | 148.296 | 47.87 | 154.7 | 62.411 | 35.718 | 21.754 | 15.64 | 9.181 | 6.395 | 3.242 |
Selling & Marketing Expenses
| 792.067 | 815.145 | 878.708 | 856.758 | 1,290.46 | 1,244.005 | 702.623 | 215.85 | 63.737 | 69.766 | 48.572 | 34.102 | 57.166 | 53.928 | 53.219 | 42.133 | 36.096 | 35.066 | 34.757 | 92.253 | 71.966 | 62.014 | 213.005 | 60.282 | 38.702 | 25.475 | 34.205 | 25.706 | 22.936 | 18.401 |
SG&A
| 881.734 | 840.658 | 908.807 | 962.146 | 1,363.859 | 1,298.527 | 742.333 | 259.978 | 78.591 | 88.005 | 62.364 | 45.918 | 98.936 | 87.704 | 87.026 | 72.754 | 66.985 | 70.248 | 70.217 | 274.852 | 220.262 | 109.883 | 367.705 | 122.692 | 74.42 | 47.229 | 49.844 | 34.887 | 29.332 | 21.643 |
Other Expenses
| -2.028 | 82.946 | 67.344 | 49.423 | 78.757 | 1.455 | 0.23 | 15.155 | 1.197 | -7.292 | 1.953 | -1.781 | 4.922 | 4.237 | 8.476 | 1.821 | 7.088 | 2.813 | -0.198 | -9.687 | -17.078 | 37.149 | -209.585 | 52.296 | 22.658 | 18.896 | 8.957 | 2.077 | -0.382 | -0.003 |
Operating Expenses
| 928.693 | 988.512 | 1,039.667 | 1,061.899 | 1,509.528 | 1,442.805 | 893.282 | 363.785 | 116.03 | 123.649 | 91.733 | 75.391 | 101.268 | 89.887 | 88.993 | 74.744 | 68.842 | 71.896 | 71.592 | 275.338 | 221.04 | 112.346 | 369.734 | 130.778 | 77.391 | 49.479 | 52.74 | 36.293 | 30.481 | 21.936 |
Operating Income
| 123.629 | 139.167 | 146.089 | -174.398 | 158.678 | 407.791 | 299.691 | 233.759 | 4.808 | 16.019 | 3.248 | 6.858 | 11.486 | 7.106 | 20.578 | 14.776 | 12.377 | 5.711 | 8.789 | -275.025 | -178.484 | -20.621 | -366.587 | 265.801 | 93.917 | 102.892 | 103.927 | 75.391 | 52.427 | 24.8 |
Operating Income Ratio
| 0.085 | 0.095 | 0.096 | -0.157 | 0.08 | 0.195 | 0.197 | 0.275 | 0.024 | 0.077 | 0.022 | 0.054 | 0.063 | 0.042 | 0.122 | 0.092 | 0.082 | 0.04 | 0.062 | -2.754 | -1.304 | -0.128 | -3.65 | 0.527 | 0.33 | 0.38 | 0.431 | 0.46 | 0.396 | 0.249 |
Total Other Income Expenses Net
| -65.033 | -88.993 | -86.466 | -181.434 | -2,171.423 | 98.864 | -4.141 | 27.213 | 20.651 | 3.335 | 21.387 | 10.123 | 12.555 | -2.794 | 15.444 | -4.176 | 3.914 | 4.991 | -2.129 | -59.673 | -59.604 | 7.584 | -275.911 | 14.464 | 10.692 | 9.395 | -0.258 | -2.088 | 0.522 | -2.853 |
Income Before Tax
| 58.597 | 50.174 | 59.624 | -355.832 | -2,012.745 | 409.246 | 299.921 | 247.781 | 5.733 | 8.725 | 5.201 | 5.077 | 16.408 | 11.058 | 29.054 | 16.597 | 19.532 | 8.465 | 8.623 | -284.775 | -194.725 | 16.664 | -575.928 | 317.747 | 115.447 | 119.207 | 112.784 | 77.638 | 52.051 | 24.751 |
Income Before Tax Ratio
| 0.04 | 0.034 | 0.039 | -0.32 | -1.018 | 0.195 | 0.197 | 0.291 | 0.029 | 0.042 | 0.035 | 0.04 | 0.09 | 0.065 | 0.173 | 0.104 | 0.129 | 0.06 | 0.061 | -2.851 | -1.422 | 0.104 | -5.734 | 0.63 | 0.405 | 0.44 | 0.468 | 0.474 | 0.393 | 0.249 |
Income Tax Expense
| 11.629 | 20.985 | 25.635 | 4.828 | 30.191 | 80.026 | 42.832 | 35.86 | -1.131 | 3.559 | 1.109 | 1.221 | 5.166 | -0.961 | -0.737 | -0.583 | 0.703 | 17.031 | 0 | -50.566 | -15.156 | 67.845 | 7.016 | 70.378 | 33.659 | 32.573 | 17.18 | 11.642 | 5.188 | 1.9 |
Net Income
| 43.934 | 30.151 | 35.273 | -360.66 | -2,042.936 | 330.858 | 257.879 | 213.461 | 6.863 | 5.166 | 4.092 | 3.857 | 11.241 | 12.019 | 29.791 | 17.18 | 18.829 | 16.51 | 8.476 | -245.679 | -194.27 | 16.417 | -584.125 | 241.915 | 81.346 | 83.31 | 95.484 | 65.996 | 46.863 | 22.851 |
Net Income Ratio
| 0.03 | 0.021 | 0.023 | -0.324 | -1.033 | 0.158 | 0.17 | 0.251 | 0.035 | 0.025 | 0.028 | 0.03 | 0.062 | 0.071 | 0.177 | 0.107 | 0.124 | 0.117 | 0.06 | -2.46 | -1.419 | 0.102 | -5.816 | 0.48 | 0.286 | 0.307 | 0.396 | 0.403 | 0.354 | 0.23 |
EPS
| 0.046 | 0.031 | 0.037 | -0.37 | -2.11 | 0.34 | 0.27 | 0.23 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.07 | 0.04 | 0.04 | -0.02 | 0.019 | -0.57 | -0.45 | 0.037 | -1.36 | 0.54 | 0.18 | 0.17 | 0.25 | 0.15 | 0.11 | 0.053 |
EPS Diluted
| 0.046 | 0.031 | 0.037 | -0.37 | -2.11 | 0.34 | 0.27 | 0.23 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.07 | 0.04 | 0.04 | -0.02 | 0.019 | -0.57 | -0.45 | 0.037 | -1.36 | 0.54 | 0.18 | 0.17 | 0.25 | 0.15 | 0.11 | 0.053 |
EBITDA
| 198.659 | 210.785 | 215.477 | -80.518 | 226.517 | 414.548 | 400.095 | 324.93 | 29.274 | 36.024 | 30.226 | 19.289 | 26.412 | 42.217 | 24.087 | 45.054 | 38.775 | 23.753 | 28.702 | -221.713 | -132.443 | 91.469 | -475.945 | 386.582 | 116.892 | 127.589 | 112.942 | 79.895 | 51.536 | 27.559 |
EBITDA Ratio
| 0.136 | 0.143 | 0.142 | -0.072 | 0.115 | 0.198 | 0.263 | 0.382 | 0.148 | 0.173 | 0.205 | 0.151 | 0.146 | 0.249 | 0.143 | 0.282 | 0.256 | 0.168 | 0.203 | -2.22 | -0.967 | 0.568 | -4.739 | 0.767 | 0.41 | 0.471 | 0.469 | 0.488 | 0.389 | 0.277 |